Association betweenEGF+61A/G polymorphism and gastric cancer in Caucasians
Open Access
- 1 January 2011
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 17 (4) , 488-92
Abstract
To investigate the association between epidermal growth factor (EGF) +61A/G polymorphism and susceptibility to gastric cancer, through a cross-sectional study. Polymerase chain reaction restriction fragment length polymorphism analyses were used to genotype EGF +61 in 207 patients with gastric lesions (162 patients with gastric adenocarcinomas, 45 with atrophy or intestinal metaplasia) and 984 controls. All subjects were Caucasian. Genotype distribution was 23.5% for GG and 76.5% for GA/AA in the control group, 18.4% for GG and 68.6% for GA/AA in the entire group with gastric lesions and 17.9% for GG and 82.1% for GA/AA in the group with gastric adenocarcinoma. No statistically significant associations were found between EGF +61 variants and risk for developing gastric cancer [odds ratios (OR) = 1.41, 95% confidence intervals (CI): 0.90-2.21, P = 0.116]. However, the stratification of individuals by gender revealed that males carrying A alleles (EGF +61A/G or AA) had an increased risk for developing gastric cancer as compared to GG homozygous males (OR = 1.55, 95% CI: 1.05-2.28, P = 0.021). In summary, we found that males who were A carriers for EGF +61 had an increased risk for developing gastric cancer. This result may be explained by the suggestion that women secrete less gastric acid than men.Keywords
This publication has 36 references indexed in Scilit:
- Ovarian Cancer and Genetic Susceptibility: Association of A61G Polymorphism in the EGF GeneExperimental Biology and Medicine, 2009
- Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high‐risk Chinese populationCancer Science, 2007
- Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: Implications for cancer therapyCellular Signalling, 2006
- Gastric cancer in a Caucasian population: Role of pepsinogen C genetic variantsWorld Journal of Gastroenterology, 2006
- No Association Between EGF Gene Polymorphism and Gastric CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- Oncogenic growth factor receptors: implications for signal transduction therapySeminars in Cancer Biology, 2004
- Regulation of gastrointestinal mucosal growth during aging.2003
- Epidermal Growth Factor Receptor Dependence in Human Tumors: More Than Just Expression?The Oncologist, 2002
- Association between functional polymorphism in EGF gene and malignant melanomaThe Lancet, 2002
- INHIBITION OF OVARIAN AND TESTICULAR STEROIODOGENESIS BY EPIDERMAL GROWTH FACTOREndocrinology, 1981